Well, I guess I can answer my own question and that's is

New Post Public Reply Private Reply Replies (2) Message Board
MGK_2 ohm20 #124859
558
Well, I guess I can answer my own question and that's is our current sub-cutaneous approach reaches a functional cure, but I believe they are seeking an outright TOTAL cure by their statement:

Quote:
there is an urgent need to design a functional cure via elimination of the viral reservoir.


If you eliminate the viral reservoir and you drive viral load to zero, you have effected a Total Cure.

They also say a functional cure is devoid of CCR5:
Quote:
While a CCR5-deficient immune system can demonstrably yield a functional HIV cure,

In fact, this is a Total Cure.

Since what you state here is correct:
Quote:
Leronlimab already acts as a functional cure in quite a large percentage of patients. In combo therapy with leronlimab 81% of patients were less than 50 c/ml which I believe was 350mg. In monotherapy I believe it was 91% or 92% of patients that were under 50 c/ml at 700mg.


Why are they spending the $1million annually to get this achieved? It is because they want what you have said PLUS they want to eradicate the reservoir which our current solution does not do.

The proposed solution is to:
Quote:
Deliver these therapeutics to the relevant immune cell type. In specific aim 1, we will generate and characterize AAV bearing capsids that target T and B cells specifically across both macaques and humans. In aim 2, we will demonstrate proof-of-concept utility of these new AAVs by delivering Leronlimab to SHIV-infected, ART suppressed macaques to determine if a functional cure can be achieved with this approach. This work would expand our knowledge of the mechanism of HIV cure by showing the utility of long-term antibody-based competitive CCR5 inhibition and establish a new set of AAV vectors to support in vivo delivery of anti-HIV therapeutics.


Certainly, they believe the Reservoir of HIV resides in the T and B cells. But what if HIV is in the NKCs, the Macrophages, the Dendrites, the monophils, eosinophils, basophills. What if they are in the platelets? What if they are in the brain or in the GI tract cells?

And what are these capsids to do? Infect the targeted T and B cells. Then what? Release Leronlimab? What good would that do? For HIV, LL acts as entry inhibitor. Entry into CD4 T lymphocytes. When these capsids enter the T and B cells, and if they find dormant HIV there, releasing LL won't stimulate them to action. If the viral capsid causes the T and B cells to lyse and open thereby releasing both the LL and the dormant HIV, then I would understand that LL would have greater affinity to the CCR5 receptor and bind instead of the dormant now active HIV.

But what is the plan, to cause all the B cells and T cells to lyse?
I have to read about this some more, but if anyone could enlighten me...

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Sports Leagues Confront Youth Gambling's Hard Truth

Updated Category News Views 35

A stadium-sized advertising machine cannot pretend kids are not watching. That is the uncomfortable backdrop to the National Council on Problem Gambling's November 10 youth gambling prevention summit, where representatives from the NFL, MLB, NBA and PGA Tour met at the NFL's New York offices. Good that they showed up. Frankly, with gambling stitched into so much sports...

Continue Reading
Anduin Opens Its Investor Portal Beyond Early Users

Updated Category News Views 68

Private-market paperwork has long been a swamp of portals, PDFs, email chains, and somebody chasing down a wire change at the worst possible moment. Anduin is taking a swing at that mess by opening its Investor Portal to all customers after building it with leading asset managers and operating it with their investors. The pitch is sensible: give limited partners one...

Continue Reading
Trip.Best Expands Global Travel Discovery Footprint

Updated Category News Views 123

Sydney just became the map pin for a fairly serious travel-content land grab. Trip.Best, Trip.com Group's ranking brand, has rolled out its 2027 Annual Rankings with coverage of all seven continents for the first time. This is not an earnings release, and nobody should pretend a hotel list magically turns into revenue by lunchtime. Still, the jump from 85 to 98 annual...

Continue Reading
Morrison Tests Abu Dhabi as Its Next Capital Hub

Updated Category News Views 60

Abu Dhabi keeps collecting infrastructure managers the way a strong port collects ships: because the money, the policy ambition, and the projects are all converging there. Morrison’s decision to establish an office in ADGM is not some chest-thumping headline about instant deal flow. It is a practical move by a firm with nearly four decades behind it and more than US$35...

Continue Reading
Saturn and Tileward Put GPU Memory Back to Work Now

Updated Category News Views 49

GPU memory is the tollbooth nobody notices until the whole AI highway backs up. Saturn Cloud’s new partnership with Tileward goes straight at that constraint: use compressed open-model weights, free memory on hardware already installed, and turn that reclaimed capacity into more tokens that an operator can actually sell. It is not glamorous. It may be one of the more...

Continue Reading
TCL CSOT's Oxide Leap Gives LCD a Sharper Fight Ahead

Updated Category News Views 64

Fifty-one point six is the number that makes this announcement worth chewing on. TCL CSOT says it has moved ultrahigh-mobility oxide technology into mass production on an 8.6-generation line, clearing the 50 cm² V?¹ s?¹ threshold that has largely belonged to lab-talk and presentation slides. For display people, that is not decorative science. It could change the old...

Continue Reading
Huhtamaki Maps Its 2027 Reporting Dates for Investors

Updated Category News Views 96

A calendar release rarely makes the pulse race, but it tells shareholders when the curtain will actually go up. Huhtamäki Oyj has laid out its 2027 financial reporting timetable, and the useful part is its plainness: investors now know the handful of dates when management will have to put numbers, not broad ambitions, in front of the market. For a packaging company, that...

Continue Reading
Prospera’s DFW Culture Win Matters Beyond the Plaque

Updated Category News Views 46

Employee survey ballots rarely make pulses race, but this one deserves more than a lazy shrug. Prospera Financial Services has landed on The Dallas Morning News’ 2026 Top Workplaces DFW list for a second consecutive year, placing in the Top Small Workplaces category. For a boutique independent broker-dealer, that is not meaningless wall décor. The people doing the...

Continue Reading
Teva’s R&D Exit Puts Disclosure Questions in Focus

Updated Category News Views 33

An abrupt departure in the drug business is never just an HR memo. Teva Pharmaceutical Industries shares reportedly dropped about 8.74% after Eric Hughes, the company’s executive vice president of Global R&D and chief medical officer, left effective immediately. That kind of move rattles investors because R&D leadership is not decorative furniture at a pharmaceutical...

Continue Reading
New York Gala Puts $3 Million Behind EB Research Work

Updated Category News Views 54

Three million dollars changes the temperature in a research room, even if it does not magically solve the hard part. EB Research Partnership said its New York gala raised more than $3 million, with Eddie Vedder, Hozier, Tom Holland and Colin Farrell among the names helping draw attention. For a nonprofit operating around research, that is not a fluffy society-page...

Continue Reading

Top 5 Most Recently Viewed Articles

Winter Weather in California: Safeguarding Your Home's Integrity

Updated Category News Views 107

California's Winter Weather: A Wake-Up Call for Homeowners As California braces for a challenging winter season characterized by heavy rains and potential flash floods, homeowners must recognize the structural risks to their properties. Alpha Structural, Inc. emphasizes the importance of proactive measures to safeguard homes against these weather-related threats....

Continue Reading
WELL Health Advances with Expanding Clinics and Public Sector Growth

Updated Category News Views 322

WELL Health's Growing Clinics and Services WELL Health Technologies Corp. is making significant strides in the Canadian healthcare landscape. Recently, the company reported expanding its network by adding 11 new clinics, a move that reflects its commitment to enhancing healthcare access and quality across the country. This new addition comprises 9 clinics acquired and 2...

Continue Reading
Growth Surge in Australia's Construction Market Expected Until 2029

Updated Category News Views 162

Overview of Australia's Construction Market Growth The Australian construction landscape is poised for a significant transformation, anticipating a remarkable growth spurt of USD 42.1 billion from 2025 to 2029. As urban migration steadily rises, the demand for diverse construction projects, encompassing both residential and commercial sectors, is increasingly pronounced....

Continue Reading
Market Insights: Indonesian Stocks Encounter Declines Today

Updated Category News Views 251

Market Overview: Indonesian Stocks on the Decline Today’s trading session in Indonesia witnessed a downward trend, as the stock market closed with losses influenced primarily by the Financials, Agriculture, and Basic Industry sectors. This decline reflects broader market sentiments and economic factors affecting investor decisions. IDX Composite Index Performance The...

Continue Reading
Dowlais Group plc and Recent Share Dealings Analysis

Updated Category News Views 193

Understanding Recent Dealings In Dowlais Group Plc Investors have been keenly observing the movements and transactions of Dowlais Group Plc, particularly as the company continues to navigate the complexities of the market. A significant reporting came in the form of disclosures related to share purchases and sales, which are vital for understanding the company's financial...

Continue Reading